Approximately 50% of sarcomas, notably leiomyosarcomas, chondrosarcomas, liposarcomas, and UPS, expressed programmed death ligand-1 (PD-L1) based on immunohistochemistry and presented PD-1+ Tumor-Infiltrating Lymphocytes (TIL) [77]. This evidence concerns the gene CD274 and sarcoma.